About Sleepio (SleepioRx)
Sleepio is a self-guided cognitive behavioral therapy for insomnia (CBT-I) program from Big Health. Over about six weeks you work through app sessions covering sleep restriction, stimulus control, managing racing thoughts and relaxation, and keep a sleep diary that sets your sleep window. In the US the prescription version, SleepioRx, is FDA-cleared for adults 18 and over: a clinician orders it and you get an access code by text. Since January 2025 clinicians can bill Medicare for it under digital mental health treatment codes, with usual Medicare coinsurance. The non-prescription Sleepio app is offered through some employers and plans; Big Health lists no self-pay price. Sleepio has been tested in several large randomised trials, including a 2019 JAMA Psychiatry trial of 1,711 adults and the 2017 OASIS trial of 3,755 students in Lancet Psychiatry, both showing improved insomnia compared with sleep hygiene education or usual care.